StemCells, Inc. to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences plc (Centre Daily Times)
StemCells, Inc. (NASDAQ:STEM) and Stem Cell Sciences plc (AIM:STEM) (ASX:STC) announced today that they have entered into a definitive agreement pursuant to which StemCells will acquire the operating subsidiaries and certain related assets of Stem Cell Sciences (SCS) for 2,650,000 shares of StemCells common stock and approximately $715,000 in cash. Stem Cell Sciences is a UK-based company …
[Read the full article here]Related News:
StemCells, Inc. To Acquire Cell-Based Drug Discovery Platforms And Related Businesses Of Stem Cell Sciences plc
StemCells, Inc. Closes Its Acquisition of the Operating Assets and Businesses of Stem Cell Sciences Plc
Stem Cell Sciences Shareholders Support Sale to StemCells